Yahoo
Tokyo - Delayed Quote JPY

Shionogi & Co., Ltd. (4507.T)

2,912.50 +3.00 (+0.10%)
At close: 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 4507.T
  • Previous Close 2,909.50
  • Open 2,891.00
  • Bid 2,906.00 x --
  • Ask 2,913.00 x --
  • Day's Range 2,891.00 - 2,927.00
  • 52 Week Range 2,392.50 - 3,758.00
  • Volume 1,463,300
  • Avg. Volume 2,716,266
  • Market Cap (intraday) 2.478T
  • Beta (5Y Monthly) 0.03
  • PE Ratio (TTM) 12.09
  • EPS (TTM) 240.91
  • Earnings Date (est.) Oct 29, 2026
  • Forward Dividend & Yield 76.00 (2.61%)
  • Ex-Dividend Date Sep 29, 2026
  • 1y Target Est 3,383.33

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.

www.shionogi.com

6,223

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 8/28/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

4507.T
3.64%
Nikkei 225 (^N225)
31.92%

1-Year Return

4507.T
16.45%
Nikkei 225 (^N225)
55.05%

3-Year Return

4507.T
46.30%
Nikkei 225 (^N225)
106.42%

5-Year Return

4507.T
42.54%
Nikkei 225 (^N225)
140.24%

Earnings Trends

View More

Earnings Per Share (GAAP)

Analyst Insights

View More

Analyst Price Targets

2,900.00
3,383.33 Average
2,912.50 Current
4,000.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    2.48T

  • Enterprise Value

    2.55T

  • Trailing P/E

    12.07

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.96

  • Price/Book (mrq)

    1.40

  • Enterprise Value/Revenue

    5.09

  • Enterprise Value/EBITDA

    9.28

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    46.79%

  • Return on Assets (ttm)

    3.22%

  • Return on Equity (ttm)

    16.77%

  • Revenue (ttm)

    563.21B

  • Net Income Avi to Common (ttm)

    263.5B

  • Diluted EPS (ttm)

    240.91

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    298.94B

  • Total Debt/Equity (mrq)

    38.59%

  • Levered Free Cash Flow (ttm)

    -5.31B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: